Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer

Gastric Cancer

Volumn 14, Issue 4, 2011, Pages 317-321

  Liamarkopoulos, Emmanouil ^a   Gazouli, Maria ^b   Aravantinos, Gerasimos ^c   Tzanakis, Nikolaos ^d   Theodoropoulos, George ^b   Rizos, Spyros ^a   Nikiteas, Nikolaos ^d  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Agioi Anargyroi Oncology Hospital   (Greece)

^d LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Caspase 8; Caspase 9; Gastric cancer; Gene polymorphisms

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CASPASE 8 GENE; CASPASE 9 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GREECE; HISTOPATHOLOGY; HUMAN; INDEL MUTATION; MALE; ONCOGENE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; STOMACH CARCINOGENESIS;

AGED; CASE-CONTROL STUDIES; CASPASE 8; CASPASE 9; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; STOMACH NEOPLASMS;

EID: 84855646985     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0045-1     Document Type: Article

References (17)

1. Compare D, Rocco A, Nardone G. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci. 2010;14:302-8.
2. Wang W, Spitz MR, Yang H, Lu C, Stewart DJ, Wu X. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res. 2007;13:5974-81. (Pubitemid 47583926)
3. Ye Y, Yang H, Grossman HB, Dinney C, Wu X, Gu J. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer. 2008;112:2467-74.
4. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis. 2004;9:691-704. (Pubitemid 40941198)
5. Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem Sci. 1997;22:299-306. (Pubitemid 27327087)
6. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet. 2007;39:352-8. (Pubitemid 46328496)
7. Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet. 2007;39:605-13. (Pubitemid 46676113)
8. Haiman CA, Garcia RR, Kolonel LN, Henderson BE, Wu AH, Le Marchand L. A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat Genet. 2008;40:259-60. (Pubitemid 351311777)
9. Gangwar R, Mandhani A, Mittal RD. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population. Ann Surg Oncol. 2009;16:2028-34.
10. Soung YH, Lee JW, Kim SY, Jang J, Park YG, Park WS, et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res. 2005;65:815-21. (Pubitemid 40216439)
11. Theodoropoulos GE, Michalopoulos NV, Panoussopoulos SG, Taka S, Gazouli M. Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas. 2010;39:976-80.
12. Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY, et al. Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas. APMIS. 2006;114:292-7.
13. Freedman ML, Penney KL, Stram DO, Le Marchand L, Hirschhorn JN, Kolonel LN, et al. Common variation in BRCA2 and breast cancer risk: A haplotype-based analysis in the Multiethnic Cohort. Hum Mol Genet. 2004;13:2431-41. (Pubitemid 39377847)
14. Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, et al. Down-regulation of caspase 3 in breast cancer: A possible mechanism for chemoresistance. Oncogene. 2002;21:8843-51. (Pubitemid 36132404)
15. Pittman AH, Broderick P, Sullivan K, Fielding S, Webb E, Penegar S, et al. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br J Cancer. 2008;98:1434-6. (Pubitemid 351543579)
16. Twiddy D, Cain K. Caspase-9 cleavage, do you need it? J Biochem. 2007;405:e1-2.
17. Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, et al. Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet. 2006;1:1963-71. (Pubitemid 43983270)